Fake Ozempic drugs found in US drug supply, FDA warns [FOX News]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: FOX News
As counterfeit Ozempic circulates in the U.S., the Food and Drug Administration has issued a warning to Americans. In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that "several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg" were in the U.S. drug supply chain. Ozempic is an injectable medication approved to treat type 2 diabetes. Wegovy, the same drug but at a higher dose, is approved to treat obesity "The counterfeit products were distributed outside the Novo Nordisk authorized supply chain in the U.S.," the FDA stated in its announcement. "FDA seized the identified counterfeit products on April 9, 2025." The FDA has advised patients, wholesalers, retail pharmacies and healthcare professionals to check any Ozempic products in their possession. Any medications labeled with lot number PAR0362 and with a serial number starting with the first eight digits 51746517 should not be used, so
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss [Yahoo! Finance]Yahoo! Finance
- SA analyst upgrades/downgrades: NVO, INTC, ADBE, WDAY [Seeking Alpha]Seeking Alpha
- EU committee backs extending use of Lilly's diabetes drug for children aged 10 and above [Yahoo! Finance Canada]Yahoo! Finance Canada
- High-end Swiss chocolatier Läderach rules out U.S. production despite tariff shock [CNBC]CNBC
- Weight-loss drug developers line up to tap lucrative market as competition heats up [BNN Bloomberg (Canada)]BNN Bloomberg
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- 11/17/25 - Form 6-K
- NVO's page on the SEC website